Key regulators of cell-cycle progression and inflammation, including Cyclin D1, Cyclin D2, COX-2 were shown to be favorably modulated by Anthos, with the most dramatic reductions in expression observed in tumor tissue samples. The gene discussed is CCND2; the disease is neoplasm.